IHM-antiPD-1

N/A

Report date: 2025/03/20 15:00:57

Base Information

Drug NameIHM-antiPD-1
Drug Alias NamePD-1 checkpoint inhibitor (MaxiVax)
ClassificationVaccines > Application > Therapeutic vaccineCell and gene therapy > Cell therapy
Mechanisms of ActionProgrammed cell death protein 1 blockersGranulocyte-macrophage colony-stimulating factor receptor stimulants
TargetsProgrammed cell death protein 1Granulocyte-macrophage colony-stimulating factor receptor
Therapy Area/IndicationsSolid tumours
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySwitzerland
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesMaxivax Sa
China Registration ClassN/A

Develop Information

Active CompaniesMaxivax Sa
Inactive CompaniesN/A
Active IndicationsSolid tumours
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A